Prolongation of cardiac allograft survival by a novel population of autologous CD117+ bone marrow-derived progenitor cells

American Journal of Transplantation

Volumn 11, Issue 1, 2011, Pages 34-44

  Grazia, T J ^a,b,c   Plenter, R J ^a,b   Lepper, H M ^a,b   Victorino, F ^a,b   Miyamoto, S D ^d   Crossno Jr , J T ^b   Pietra, B A ^b,d   Gill, R G ^b,c,e   Zamora, M R ^a,b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COLORADO DENVER   (United States)

^c NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^d CHILDREN S HOSPITAL COLORADO   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

Acute allograft rejection; stem cells; tolerance induction; transplantation

Indexed keywords

STEM CELL FACTOR RECEPTOR;

ACUTE GRAFT REJECTION; ADAPTIVE IMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CARDIAC GRAFT REJECTION; CD117+ PROGENITOR CELL THERAPY; CELL PROTECTION; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TREATMENT OUTCOME;

ANIMALS; BONE MARROW CELLS; BONE MARROW TRANSPLANTATION; GRAFT SURVIVAL; HEART TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; PROTO-ONCOGENE PROTEINS C-KIT; STEM CELLS; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 78650908311     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03335.x     Document Type: Article

References (53)

1. Taylor DO, Stehlik J, Edwards LB, et al,. Registry of the international society for heart and lung transplantation: Twenty-sixth official adult heart transplant report-2009. J Heart Lung Transplant 2009; 28: 1007-1022.
2. Johnson MR, Meyer KH, Haft J, Kinder D, Webber SA, Dyke DB,. Heart transplantation in the United States, 1999-2008. Am J Transplant 2010; 10: 1035-1046.
3. Burt RK, Loh Y, Pearce W, et al,. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. JAMA 2008; 299: 925-936.
4. Dimmeler S, Burchfield J, Zeiher AM,. Cell-based therapy of myocardial infarction. Arterioscler Thromb Vasc Biol 2008; 28: 208-216.
5. Kawamoto A, Losordo DW,. Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc Med 2008; 18: 33-37.
6. Bertolini F, Mancuso P, Shaked Y, and, Kerbel RS,. Molecular and cellular biomarkers for angiogenesis in clinical oncology. Drug Discov Today 2007; 12: 806-812.
7. Shi Q, Rafii S, Wu MH, et al,. Evidence for circulating bone marrow-derived endothelial cells. Blood 1998; 92: 362-367.
8. Bhattacharya V, McSweeney PA, Shi Q, et al,. Enhanced endothelialization and microvessel formation in polyester grafts seeded with CD34(+) bone marrow cells. Blood 2000; 95: 581-585.
9. Stump MM, Jordan GL Jr,., Debakey ME, Halpert B,. Endothelium grown from circulating blood on isolated intravascular Dacron Hub. Am J Pathol 1963; 43: 361-367.
10. Wu MH, Shi Q, Wechezak AR, Clowes AW, Gordon IL, Sauvage LR,. Definitive proof of endothelialization of a Dacron arterial prosthesis in a human being. J Vasc Surg 1995; 21: 862-867.
11. Grazia TJ, Pietra BA, Johnson ZA, Kelly BP, Plenter RJ, and, Gill RG,. A two-step model of acute CD4 T cell mediated cardiac allograft rejection. J Immunol 2004; 172: 7451-7458.
12. Hirschi KK., Ingram DA, Yoder MC,. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008; 28: 1584-1595.
13. Yoder MC, Mead LE, Prater D, et al,. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 2007; 109: 1801-1809.
14. Lyman SD, Jacobsen SE,. c-kit ligand and Flt3 ligand: Stem/progenitor cell factors with overlapping yet distinct activities. Blood 1998; 91: 1101-1134.
15. Rohde E, Malischnik C, Thaler D, et al,. Blood monocytes mimic endothelial progenitor cells. Stem Cells 2006; 24: 357-367.
16. Zhang SJ, Zhang H, Wei YJ, et al,. Adult endothelial progenitor cells from human peripheral blood maintain monocyte/macrophage function throughout in vitro culture. Cell Res 2006; 16: 577-584.
17. Rehman J, Li J, Orschell CM, March KL,. Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors. Circulation 2003; 107: 1164-1169.
18. Rohde E, Bartmann C, Schallmoser K, et al,. Immune cells mimic the morphology of endothelial progenitor colonies in vitro. Stem Cells 2007; 25: 1746-1752.
19. De Palma M, Venneri MA, Galli R, et al,. Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 2005; 8: 211-226.
20. Zentilin L, Tafuro S, Zacchigna S, et al,. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood 2006; 107: 3546-3554.
21. Jin DK, Shido K, Kopp HG, et al,. Cytokine-mediated deployment of SDF-1 induces revascularization through recruitment of CXCR4+ hemangiocytes. Nat Med 2006; 12: 557-567.
22. You D, Waeckel L, Ebrahimian TG, et al,. Increase in vascular permeability and vasodilation are critical for proangiogenic effects of stem cell therapy. Circulation 2006; 114: 328-338.
23. Rafii S, Lyden D,. Cancer. A few to flip the angiogenic switch. Science 2008; 319: 163-164.
24. Anghelina M, Krishnan P, Moldovan L, Moldovan NI,. Monocytes/macrophages cooperate with progenitor cells during neovascularization and tissue repair: Conversion of cell columns into fibrovascular bundles. Am J Pathol 2006; 168: 529-541.
25. Sood R, Kalloway S, Mast AE, Hillard CJ, Weiler H,. Fetomaternal cross talk in the placental vascular bed: Control of coagulation by trophoblast cells. Blood 2006; 107: 3173-3180.
26. Davie NJ, Crossno JT Jr,., Frid MG, et al,. Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: Contribution of progenitor cells. Am J Physiol Lung Cell Mol Physiol 2004; 286: L668-678.
27. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM,. Origin of endothelial progenitors in human postnatal bone marrow. J Clin Invest 2002; 109: 337-346.
28. Young HE, Steele TA, Bray RA, et al,. Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 2001; 264: 51-62.
29. Orlic D, Kajstura J, Chimenti S, et al,. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. ProcNat. Acad Sci U S A 2001; 98: 10344-10349.
30. Sata M, Saiura A, Kunisato A, et al,. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med 2002; 8: 403-409.
31. Crossno JT Jr,., Majka SM, Grazia T, Gill RG, Klemm DJ,. Rosiglitazone promotes development of a novel adipocyte population from bone marrow-derived circulating progenitor cells. J Clin Invest 2006; 116: 3220-3228.
32. Ogawa M, Nishikawa S, Yoshinaga K, et al,. Expression and function of c-Kit in fetal hemopoietic progenitor cells: Transition from the early c-Kit-independent to the late c-Kit-dependent wave of hemopoiesis in the murine embryo. Development 1993; 117: 1089-1098.
33. Laing AJ, Dillon JP, Condon ET, et al,. A systemic provascular response in bone marrow to musculoskeletal trauma in mice. J Bone Joint Surg Br 2007; 89: 116-120.
34. Patschan D, Krupincza K, Patschan S, Zhang Z, Hamby C, Goligorsky MS,. Dynamics of mobilization and homing of endothelial progenitor cells after acute renal ischemia: Modulation by ischemic preconditioning. Am J Physiol Renal Physiol 2006; 291: F176-185.
35. Dentelli P, Rosso A, Balsamo A, et al,. C-KIT, by interacting with the membrane-bound ligand, recruits endothelial progenitor cells to inflamed endothelium. Blood 2007; 109: 4264-4271.
36. Lupatov AY, Karalkin PA, Suzdal'tseva YG, Burunova VV, Yarygin VN, Yarygin KN,. Cytofluorometric analysis of phenotypes of human bone marrow and umbilical fibroblast-like cells. Bull Exp Biol Med 2006; 142: 521-526.
37. Martin-Rendon E, Sweeney D, Lu F, Girdlestone J, Navarrete C, Watt SM,. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies. Vox Sang 2008; 95: 137-148.
38. Shih YR, Kuo TK, Yang AH, Lee OK, Lee CH,. Isolation and characterization of stem cells from the human parathyroid gland. Cell Prolif 2009; 42: 461-470.
39. Grazia TJ, Plenter RJ, Weber SM, et al,. Acute cardiac allograft rejection by directly cytotoxic CD4 T cells: Parallel requirements for Fas and perforin. Transplantation 2010; 89: 33-39.
40. Grazia TJ, Plenter RJ, Doan AN, et al,. Spontaneous allograft tolerance in B7-deficient mice independent of preexisting endogenous CD4+CD25+ regulatory T cells. Transplantation 2007; 83: 1449-1458.
41. Corry RJ, Winn HJ, Russell PS,. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343-350.
42. Schaefer BC, Schaefer ML, Kappler JW, Marrack P, Kedl RM,. Observation of antigen-dependent CD8+ T cell/ dendritic cell interactions in vivo. Cell Immunol 2001; 214: 110-122.
43. Casiraghi F, Azzollini N, Cassis P, et al,. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J Immunol 2008; 181: 3933-3946.
44. Ge W, Jiang J, Baroja ML, et al,. Infusion of mesenchymal stem cells and rapamycin synergize to attenuate alloimmune responses and promote cardiac allograft tolerance. Am J Transplant 2009; 9: 1760-1772.
45. Li XC, Rothstein DM, Sayegh MH,. Costimulatory pathways in transplantation: Challenges and new developments. Immunol Rev 2009; 229: 271-293.
46. Zhang GY, Hu M, Wang YM, Alexander SI,. Foxp3 as a marker of tolerance induction versus rejection. Curr Opin organ transplant 2009; 14: 40-45.
47. Sagoo P, Lombardi G, Lechler RI,. Regulatory T cells as therapeutic cells. Curr Opin organ Transplant 2008; 13: 645-653.
48. Balner H,. Persistence of tolerance towards donor-type antigens after temporary chimerism in rats. Transplantation 1964; 2: 464-474.
49. Kawai T, Cosimi AB, Spitzer TR, et al,. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008; 358: 353-361.
50. Scandling JD, Busque S, Dejbakhsh-Jones S, et al,. Tolerance and chimerism after renal and hematopoietic-cell transplantation. N Engl J Med 2008; 358: 362-368.
51. Alexander SI, Smith N, Hu M, et al,. Chimerism and tolerance in a recipient of a deceased-donor liver transplant. N Engl J Med 2008; 358: 369-374.
52. Soiffer R,. Immune modulation and chronic graft-versus-host disease. Bone Marrow Transplant 2008; 42 Suppl 1: S66-S69.
53. Li FX, Zhu JW, Tessem JS, et al,. The development of diabetes in E2f1/E2f2 mutant mice reveals important roles for bone marrow-derived cells in preventing islet cell loss. Proc Natl Acad Sci U S A 2003; 100: 12935-12940.